Bridges Investment Management’s Core Laboratories CLB Stock Holding History

Bridges Investment Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,690	Closed	-$685K	–	298
2019 Q3	$685K	Hold	14,690	–	–	0.03%	247
2019 Q2	$768K	Hold	14,690	–	–	0.03%	232
2019 Q1	$1.01M	Buy	14,690 +3,130	+27%	+$210K	0.04%	191
2018 Q4	$690K	Buy	+11,560	New	+$998K	0.03%	220

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Bridges Investment Management's CLB Position: Q4 2019 in Review

Bridges Investment Management sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 14,690 shares — an estimated $685K sold.

Bridges Investment Management first reported a position in CLB in Q4 2018 and held it in 4 quarters. The position peaked at $1.01M in Q1 2019. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

Bridges Investment Management reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
Bridges Investment Management sold 14,690 Core Laboratories shares in Q4 2019, an estimated $685K.
Bridges Investment Management first reported a position in Core Laboratories in Q4 2018 and held it in 4 quarters.
Bridges Investment Management's Core Laboratories position peaked at $1.01M in Q1 2019.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Bridges Investment Management's 13F filing for Q4 2019, filed 18 Feb 2020.